nivolumab,ipilimumab
bms
['improve ', 'check,mate,914', 'rcc,(-irccs),(-srcc),(-urcc)', 'nivo', 'checkmate 914']
adjuvant nivo+ipi fails to improve dfs for localized rcc at high risk of relapse after nephrectomy: checkmate 914 trial 
Professor of Medical Oncology,  Amrita Institute of Medical  Sciences. Oncologist and Hematologist